Inactive Instrument

Analyst Reco. Tabula Rasa HealthCare, Inc.

Equities

TRHC

US8733791011

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

SVB Securities Upgrades Tabula Rasa HealthCare to Outperform From Market Perform, Adjusts Price Target to $10 From $7	23-05-10	MT
Piper Sandler Adjusts Price Target on Tabula Rasa HealthCare to $4 From $6, Maintains Neutral Rating	22-11-07	MT
Piper Sandler Adjusts Tabula Rasa HealthCare's Price Target to $6 from $3, Keeps Neutral Rating	22-08-18	MT
SVB Securities Adjusts Tabula Rasa HealthCare's Price Target to $5.50 from $4, Maintains Market Perform Rating	22-08-08	MT
Piper Sandler Adjusts Price Target on Tabula Rasa HealthCare to $3 From $13, Maintains Neutral Rating	22-06-22	MT
Stifel Adjusts Price Target on Tabula Rasa HealthCare to $5 From $6, Reiterates Hold Rating	22-06-22	MT
SVB Securities Adjusts Tabula Rasa HealthCare's Price Target to $4 from $11, Keeps Market Perform Rating	22-05-09	MT
RBC Cuts Price Target on Tabula Rasa HealthCare to $6 From $8, Maintains Outperform Rating	22-05-09	MT
SVB Leerink Adjusts Tabula Rasa HealthCare's Price Target to $11 from $23, Keeps Market Perform Rating	22-02-28	MT
RBC Slashes Price Target on Tabula Rasa HealthCare to $8 From $23, Maintains Outperform Rating	22-02-28	MT
Baird Downgrades Tabula Rasa HealthCare to Neutral From Outperform, Adjusts Price Target to $11 From $24	22-02-01	MT
Jefferies Starts Tabula Rasa HealthCare at Hold with $13 Price Target	21-12-02	MT
Benchmark Capital Adjusts Price Target on Tabula Rasa HealthCare to $30 From $55, Maintains Buy Rating	21-11-09	MT
Baird Adjusts Price Target on Tabula Rasa HealthCare to $24 From $56, Maintains Outperform Rating	21-11-08	MT
Cantor Adjusts Price Target on Tabula Rasa HealthCare to $22 From $40, Maintains Neutral Rating	21-11-08	MT
SVB Leerink Adjusts Price Target on Tabula Rasa HealthCare to $23 from $40, Keeps Market Perform Rating	21-11-08	MT
Piper Sandler Adjusts Price Target on Tabula Rasa HealthCare to $13 From $41, Maintains Neutral Rating	21-11-08	MT
RBC Slashes Price Target on Tabula Rasa HealthCare to $23 From $70, Citing 'Dampened Enthusiasm' for MedWise; Outperform Kept	21-11-08	MT
Stifel Adjusts Price Target on Tabula Rasa HealthCare to $24 From $42, Reiterates Hold Rating	21-11-08	MT
TABULA RASA HEALTHCARE : SVB Leerink Adjusts Tabula Rasa HealthCare's Price Target to $40 from $49, Keeps Market Perform Rating	21-09-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Tabula Rasa HealthCare, Inc.

Equities

TRHC

US8733791011

Analyst Reco.

Filters